Laboratory features and pharmacological management of early and late-onset primary Sjögren’s syndrome
Rheumatology International · 05.06.2024 · 44 (7) · 1317-1325
DOI: 10.1007/s00296-024-05626-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rheumatology International, online erschienen am 05.06.2024. Verfasst von Rimah A Saleem und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, Alfaisal University, P.O. Box 50927, Riyadh, 11533, Saudi Arabia. rsaleem@alfaisal.edu. Hauptthemen laut MEDLINE: Sjogren's Syndrome, Age of Onset. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Primary Sjögren’s Syndrome (pSS) is a systemic chronic autoimmune disorder that contributes to dry mouth (xerostomia) and eyes (xerophthalmia). It mainly affects females between 40 and 60 years old. So far, there is no treatment to cure SS; however, there is a list of medications that can ameliorate the symptoms. In addition, there has been no single test until now to detect pSS, but clinical and immunological investigations are applied as diagnostic tools. Therefore, this study aimed to explore the characteristics of pSS in Saudi patients based on the onset of the disease through laboratory findings and pharmaceutical management. Methodology This retrospective study examined diagnosed patients with pSS between 2018 and 2023 from the National Guard Hospital, Saudi Arabia. Data of pSS patients was categorized into two groups: early (under 40 years old) and late-onset (40 years old and above). Data on demographic information, mortality rate, and blood tests such as complete blood count (CBC), creatinine, erythrocyte sedimentation rate (ESR), and vitamin levels, in addition to prescribed medications, were collected from the patient’s medical record. Chi-square and t-tests were mainly used, and statistical significance was determined at a P -value less than 0.05.
Results
A total of 453 patients were included in the study, where the early-onset group comprised 136 and the late-onset group comprised 317 patients. The mean age of the early and late onset was 34.2 and 60.4, respectively. ESR was significantly higher in the early (46.3 mm/hr) and late-onset (49.8 mm/hr). The most common medication used by all pSS patients was hydroxychloroquine. However, artificial tears were mainly observed in the late-onset group. Other medications, such as pilocarpine, methotrexate, and azathioprine, were prescribed to pSS patients to a lesser extent.
Conclusion
This study suggests that the onset of pSS could occur even before the age of 40 among Saudi citizens. Notably, elevated ESR levels appeared to be a feature of pSS, which was consistent with other previous findings. The variability of some medications between early-onset and late-onset pSS may indicate disease progression. However, further investigations are required to confirm this observation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Medicine, Alfaisal University, P.O. Box 50927, Riyadh, 11533, Saudi Arabia. rsaleem@alfaisal.edu.
- King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia.
- College of Medicine, Alfaisal University, P.O. Box 50927, Riyadh, 11533, Saudi Arabia.
- Department of Internal Medicine and Clinical Research Institute, American University of Beirut Medical Center, Beirut, Lebanon.
- College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Zitieren
APA
Saleem, R. A., Ramadan, M., Elshaaer, Y., Sukkarieh, H., Alissa, R., Alhusseini, N., Tamim, H., Alshahrani, A., & Almaimoni, H. (2024). Laboratory features and pharmacological management of early and late-onset primary Sjögren’s syndrome. Rheumatology International, 44(7), 1317-1325. https://doi.org/10.1007/s00296-024-05626-0
Vancouver
Saleem RA, Ramadan M, Elshaaer Y, Sukkarieh H, Alissa R, Alhusseini N, et al. Laboratory features and pharmacological management of early and late-onset primary Sjögren’s syndrome. Rheumatology International. 2024;44(7):1317-1325. doi:10.1007/s00296-024-05626-0
BibTeX
@article{Saleem2024,
author = {Saleem, Rimah A and Ramadan, Majed and Elshaaer, Yasmin and Sukkarieh, Hatouf and Alissa, Rasha and Alhusseini, Noara and Tamim, Hani and Alshahrani, Awad and Almaimoni, Hesham},
title = {Laboratory features and pharmacological management of early and late-onset primary Sjögren’s syndrome},
journal = {Rheumatology International},
year = {2024},
volume = {44},
number = {7},
pages = {1317--1325},
doi = {10.1007/s00296-024-05626-0}
}
EUVIMED